Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

45.07USD
29 Jul 2016
Change (% chg)

$-0.11 (-0.24%)
Prev Close
$45.18
Open
$45.19
Day's High
$45.38
Day's Low
$44.85
Volume
2,978,330
Avg. Vol
3,472,618
52-wk High
$45.45
52-wk Low
$36.71

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.65 December 30 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 4 9,659.04 10,051.10 9,338.18 9,666.83
Quarter Ending Dec-16 4 9,676.44 10,261.50 9,152.61 10,055.70
Year Ending Dec-16 5 36,148.40 37,069.10 35,086.10 38,350.40
Year Ending Dec-17 5 37,909.30 40,380.50 35,994.10 38,886.00
Earnings (per share)
Quarter Ending Sep-16 3 0.65 0.78 0.41 --
Quarter Ending Dec-16 3 0.54 0.69 0.30 --
Year Ending Dec-16 6 2.30 2.57 1.28 2.58
Year Ending Dec-17 5 2.64 2.77 2.48 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 8,564.62 8,716.40 151.78 1.77
Quarter Ending Dec-15 8,920.50 9,617.58 697.08 7.81
Quarter Ending Sep-15 9,344.43 9,374.31 29.88 0.32
Quarter Ending Jun-15 9,141.39 9,067.52 73.87 0.81
Quarter Ending Mar-15 8,470.21 8,545.44 75.23 0.89
Earnings (per share)
Quarter Ending Mar-16 0.52 0.55 0.03 5.77
Quarter Ending Dec-15 0.49 0.55 0.06 12.24
Quarter Ending Sep-15 0.58 0.70 0.12 20.69
Quarter Ending Sep-14 0.40 0.93 0.53 129.97
Quarter Ending Dec-13 0.96 0.97 0.01 1.04

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 9,659.04 9,646.08 9,769.86 9,845.65 9,666.83
Quarter Ending Dec-16 9,676.44 9,700.48 9,840.06 9,914.93 10,055.70
Year Ending Dec-16 36,148.40 36,744.10 37,566.80 37,797.50 38,350.40
Year Ending Dec-17 37,909.30 37,944.30 38,593.20 38,832.60 38,886.00
Earnings (per share)
Quarter Ending Sep-16 0.65 0.63 0.63 0.64 --
Quarter Ending Dec-16 0.54 0.54 0.54 0.55 --
Year Ending Dec-16 2.30 2.31 2.31 2.32 2.58
Year Ending Dec-17 2.64 2.61 2.61 2.63 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 1 1 1 3
Quarter Ending Dec-16 1 1 1 3
Year Ending Dec-16 0 2 0 4
Year Ending Dec-17 2 1 2 3
Earnings
Quarter Ending Sep-16 2 0 2 0
Quarter Ending Dec-16 0 1 0 1
Year Ending Dec-16 0 2 0 2
Year Ending Dec-17 2 0 2 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.